GlassScriptPhysician profile
Monica L Arango
NPI 1073741773
$1,085.06
in general payments reported to CMS, 2019-2025
16 companies · $432 in 2025
The $432 reported for 2025 was more than what 92% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $73.72 · 2022: $30.24 · 2023: $364 · 2024: $184 · 2025: $432.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $957 · Education: $23.84.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $957.26 |
| Education | $23.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $254.16 | 2022-2025 | Lupron Depot |
| Tolmar, INC. | $154.62 | 2023-2025 | Fensolvi |
| Genzyme Corporation | $124.97 | 2025 | |
| Abbott Laboratories | $105.50 | 2023 | Freestyle Libre 3 |
| Medtronic, INC. | $104.57 | 2024-2025 | Minimed 780g |
| Neurocrine Biosciences, INC. | $71.08 | 2024-2025 | |
| Dexcom, INC. | $49.69 | 2023-2024 | Dexcom G6 Transmitter |
| Cardiovascular Systems INC. | $48.76 | 2019 | |
| Pfizer INC. | $45.61 | 2025 | |
| Biomarin Pharmaceutical INC. | $29.10 | 2025 | Voxzogo 1.2mg |
| Beta Bionics, INC. | $20.14 | 2024 | Ilet Bionic Pancreas |
| Tandem Diabetes Care, INC. | $18.88 | 2023 | T:Slim X2 Insulin Pump With Control-Iq |
| Eton Pharmaceuticals, INC. | $18.05 | 2025 | Alkindi, Khindivi, Increlex |
| Ascendis Pharma Endocrinology INC | $14.97 | 2023 | |
| Merck Sharp & Dohme LLC | $13.22 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi Pasteur INC. | $11.74 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Monica Arango listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.